Dr.Moshira is a PhD-driven researcher specializing in biomarker discovery, multi-omics integration, and radiogenomics. My primary focus is on the intersection of AI and cancer research, where I design and deploy explainable Machine Learning pipelines that enable earlier diagnosis and personalized therapeutic strategies directly within clinical pathways.
Beyond research, I am dedicated to translating complex science into tangible impact. As an Academic Lecturer and Founder, I educate the next generation in AI and computer science while building practical tools. My work has been internationally recognized, including an award from DAAD for Entrepreneurship and Innovation (TU Berlin, 2023) and 2nd place at Falling Walls Lab Cairo (2024).
Publications
Falling Walls Lab Cairo ’24
TU Berlin Innovation ’23
Recognized by IBM for instructional excellence in:
Successfully delivered industry-aligned curriculums for both academic and corporate learners, blending theory with hands-on projects.
Designed and led advanced CS & AI courses including:
Courses emphasize critical thinking, real-world applications, and cross-disciplinary integration.
OmicsFusionNet is a multi-omics integration platform designed for early cancer detection, staging, and treatment response. It combines statistical feature selection with Machine Learning and Deep Learning models. The platform also supports MSI/MSS-aware precision oncology.
Learn more →A research-driven project using AI and multi-omics to improve lung cancer detection and treatment prediction, combining imaging and genetic data for earlier, more accurate, and personalized care.
Learn more →Seq2Image is a radiogenomic pipeline that correlates pathology images with genomic signatures. Its purpose is to predict therapy choices (specifically, immunotherapy versus chemotherapy) while providing interpretability.
Learn more →A Novel Statistical Feature Selection Framework for Biomarker Discovery and Cancer Classification via Multiomics Integration.
BMC Medical Research Methodology — Under review
AI‑Based Multiomics Integration for Cancer Diagnosis and Prognosis.
Journal of Genetic Engineering and Biotechnology — Under review
Ovarian Cancer Proteome Analysis and Biomarker Discovery Using ML.
AISI 2024
Lung Cancer Stages Classification via Differential Gene Expression & DL.
AISI 2024, Springer.
Whether you're interested in research collaborations, guest speaking, mentorship, or supervision opportunities — feel free to reach out.
Reach me at: moshira.ghalib79@gmail.com
📍 Powered by Aim Learning — Hosting you forward.